EnPlusOne Biosciences on Path Towards Commercial Enzymatic RNA Synthesis
The latest George Church startup says its platform technology can deliver enzymatically synthesized RNA at a commercial scale in the near future.
Source: genomeweb.com
Stay updated with breaking news from Enplusone Cofounder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The latest George Church startup says its platform technology can deliver enzymatically synthesized RNA at a commercial scale in the near future.